Literature DB >> 7755127

Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients.

A E Wallace1, L L Kofoed, A N West.   

Abstract

OBJECTIVE: The authors examined the efficacy of methylphenidate in the treatment of depression in a group of older, medically ill patients.
METHOD: Sixteen patients underwent an 8-day double-blind, randomized, placebo-controlled crossover trial; 13 completed the trial.
RESULTS: Statistically and clinically significant treatment responses were found.
CONCLUSIONS: These results support the use of methylphenidate in older, medically ill patients in whom rapid resolution of depressive symptoms is crucial.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7755127     DOI: 10.1176/ajp.152.6.929

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  15 in total

Review 1.  Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.

Authors:  Susan E Hardy
Journal:  Am J Geriatr Pharmacother       Date:  2009-02

Review 2.  Antidepressant versus placebo for depressed elderly.

Authors:  K Wilson; P Mottram; A Sivanranthan; A Nightingale
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 3.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 4.  Use of antidepressants in older patients with co-morbid medical conditions: guidance from studies of depression in somatic illness.

Authors:  Gary J Kennedy; Paula Marcus
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 5.  Assessing the roles of stimulants/stimulant-like drugs and dopamine-agonists in the treatment of bipolar depression.

Authors:  Bernardo Dell'Osso; Terence A Ketter; Laura Cremaschi; Gregorio Spagnolin; A Carlo Altamura
Journal:  Curr Psychiatry Rep       Date:  2013-08       Impact factor: 5.285

6.  Using Psychostimulants to Treat Depression in the Medically Ill.

Authors:  Jeff C Huffman; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

Review 7.  Time course of response to antidepressants in late-life major depression: therapeutic implications.

Authors:  Ellen M Whyte; Mary Amanda Dew; Ariel Gildengers; Eric J Lenze; Ashok Bharucha; Benoit H Mulsant; Charles F Reynolds
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

8.  Randomized, double-blind, placebo-controlled study of methylphenidate for the treatment of depression in SSRI-treated cancer patients receiving palliative care.

Authors:  Donald R Sullivan; Solange Mongoue-Tchokote; Motomi Mori; Elizabeth Goy; Linda Ganzini
Journal:  Psychooncology       Date:  2016-08-12       Impact factor: 3.894

9.  Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET).

Authors:  Lea T Drye; Roberta W Scherer; Krista L Lanctôt; Paul B Rosenberg; Nathan Herrmann; David Bachman; Jacobo E Mintzer
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-18       Impact factor: 4.105

Review 10.  The role of higher-level cognitive function in gait: executive dysfunction contributes to fall risk in Alzheimer's disease.

Authors:  Pamela L Sheridan; Jeffrey M Hausdorff
Journal:  Dement Geriatr Cogn Disord       Date:  2007-07-04       Impact factor: 2.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.